Cargando…
Micropeptide MIAC inhibits the tumor progression by interacting with AQP2 and inhibiting EREG/EGFR signaling in renal cell carcinoma
BACKGROUND: Although, micropeptides encoded by non-coding RNA have been shown to have an important role in a variety of tumors processes, there have been no reports on micropeptide in renal cell carcinoma (RCC). Based on the micropeptide MIAC (micropeptide inhibiting actin cytoskeleton) discovered a...
Autores principales: | Li, Mengwei, Liu, Guangxiang, Jin, Xinrong, Guo, Hongqian, Setrerrahmane, Sarra, Xu, Xindi, Li, Tiantian, Lin, Yunfei, Xu, Hanmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484220/ https://www.ncbi.nlm.nih.gov/pubmed/36117171 http://dx.doi.org/10.1186/s12943-022-01654-1 |
Ejemplares similares
-
The Role of EREG/EGFR Pathway in Tumor Progression
por: Cheng, Wan-Li, et al.
Publicado: (2021) -
Integrins as attractive targets for cancer therapeutics
por: Li, Meng, et al.
Publicado: (2021) -
Tumor-related interleukins: old validated targets for new anti-cancer drug development
por: Setrerrahmane, Sarra, et al.
Publicado: (2017) -
Trends in insulin resistance: insights into mechanisms and therapeutic strategy
por: Li, Mengwei, et al.
Publicado: (2022) -
Micropeptide
por: Sousa, Maria E., et al.
Publicado: (2018)